Up to 40% of weight lost on GLP-1s can come from muscle
The ongoing Phase 3 programme known as the TRIUMPH trials is evaluating retatrutide across a broader population, including individuals with obesity, type 2 diabetes, and cardiovascular risk factors
Resolving Triple Engagement: Structural Biology A recurring question in the retatrutide literature is how a single peptide can act as an agonist at three related but distinct class B G-protein-coupled receptors
Contrave helps you lose weight by acting on two brain pathways at the same time
Consistency was key for generating robust data on weight loss and metabolic health, and subjects who missed multiple weekly administrations risked reducing the accuracy of the results
Mounjaro is given as a subcutaneous injection once weekly, under the skin of the stomach, thigh, or upper arm